The novel therapeutic agent PA65020 (enteric-coated aspirin plus immediate-release omeprazole) significantly reduced gastrointestinal mucosal damage after 28 days of treatment compared with ...

SPARTA, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a specialty pharmaceutical company focused on its clinically-validated and ...

People often take a daily aspirin in hopes of preventing a heart attack or stroke. Others take aspirin regularly to cope with arthritis or other aches and pains.

That’s because the 2019 study, which queried 14,328 U.S. adults about their aspirin use, was conducted in 2017, before the new research and guidelines. Advertisement ...

WASHINGTON — Older adults without heart disease shouldn't take daily low-dose aspirin to prevent a first heart attack or stroke, an influential health guidelines group said in finalized advice ...

There’s no doubt that taking low-dose daily aspirin is beneficial to most people who’ve had a heart attack or stroke. But if you don’t have heart disease, should you take it as a preventive ...

POZEN announced that the results from a Phase 1 study, PA8140-102, demonstrated that PA8140, POZEN’s proprietary combination of aspirin and omeprazole, had comparable bioavailability relative to ...

SPARTA, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), is a specialty pharmaceutical company focused on ...